Skip to main content
logo
Corvus Pharmaceuticals logo
Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.21
-0.20 (-1.92%)
At close: Oct 8, 2026, 4:00 PM EDT
10.15
-0.06 (-0.59%)
After-hours: Oct 8, 2026, 7:30 PM EDT

Corvus Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-54.13-15.28-62.29-27.03-41.31-43.24
Depreciation & Amortization
0.120.110.090.150.370.46
Loss (Gain) From Sale of Assets
---0.01--0.02-
Loss (Gain) From Sale of Investments
-0.55-1.35-1.14-0.89-0.170.24
Loss (Gain) on Equity Investments
2.341.963.25.2810.014.83
Stock-Based Compensation
8.085.3332.152.694.23
Other Operating Activities
--27.1433.38---
Change in Accounts Receivable
0.080.04-0.050.56-0.08-0.51
Change in Accounts Payable
0.91-0.091.06-0.450.41-1.9
Change in Other Net Operating Assets
-1.383.63-2.66-3.711.08-0.83
Operating Cash Flow
-44.53-32.8-25.42-23.94-27.02-36.72
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.7-0.17--0.03-0.27-0.01
Sale of Property, Plant & Equipment
--0.01-0.02-
Investment in Securities
-141.85-7.62-27.4915.58-23.0321.57
Investing Cash Flow
-142.55-7.8-27.4815.54-23.2821.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
191.2936.4335.067.86-62.16
Other Financing Activities
--13.97---
Financing Cash Flow
191.2936.4349.037.86-62.16

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
4.21-4.16-3.88-0.54-50.347

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-45.23-32.97-25.42-23.97-27.29-36.72
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.52-0.41-0.42-0.50-0.59-0.88
Levered Free Cash Flow
-27.4-46.8613.96-15.79-15.82-22.52
Unlevered Free Cash Flow
-27.4-46.8613.96-15.79-15.82-22.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.393.58-1.65-3.591.41-3.24
SEC Filings: 10-K · 10-Q